Blankson, Joel N.

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 2,119

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure

Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell

HIV Research and TreatmentVirus-based gene therapy research

Cited by 1,405

A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

Bruner, K. M., Wang, Z., Simonetti, F. R., Bender, A. M., Kwon, K. J., Sengupta, S., Fray, E. J., Beg, S. A., Antar, A. A. R., Jenike, K. M., et al. (2019) · Nature

HIV Research and TreatmentVirus-based gene therapy research

Cited by 718

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Deeks, S. G., Archin, N., Cannon, P., Collins, S., Jones, R. B., de Jong, M. A. W. P., Lambotte, O., Lamplough, R., Ndung’u, T., Sugarman, J., et al. (2021) · Nature Medicine

HIV Research and TreatmentVirus-based gene therapy research

Cited by 377

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Woldemeskel, B. A., Garliss, C. C., & Blankson, J. N. (2021) · Journal of Clinical Investigation

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 175

Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

Woldemeskel, B. A., Kwaa, A. K., Garliss, C. C., Laeyendecker, O., Ray, S. C., & Blankson, J. N. (2020) · Journal of Clinical Investigation

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 78